SC-002 is a targeted ADC being investigated to treat solid tumors.

Type of Molecule

Biologic

Target

n/a

Region

n/a

Potential Indication Product Type Phase (1, 2, 3, Submitted, Approved)
Small Cell Lung Cancer New Indication Phase 1